MOBKL2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.955570E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.868100E-02
Normal-vs-Stage2
1.620570E-03
Normal-vs-Stage3
2.762900E-03
Normal-vs-Stage4
5.774200E-01
Stage1-vs-Stage2
6.261600E-01
Stage1-vs-Stage3
2.571200E-01
Stage1-vs-Stage4
2.219200E-01
Stage2-vs-Stage3
5.219700E-02
Stage2-vs-Stage4
3.420200E-01
Stage3-vs-Stage4
1.279020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.804900E-04
Normal-vs-AfricanAmerican
3.076200E-01
Normal-vs-Asian
1.516190E-03
Caucasian-vs-AfricanAmerican
3.229400E-01
Caucasian-vs-Asian
3.714600E-01
AfricanAmerican-vs-Asian
2.063200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.800250E-03
Normal-vs-Female
2.960400E-03
Male-vs-Female
7.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.219800E-02
Normal-vs-Age(41-60Yrs)
1.059580E-02
Normal-vs-Age(61-80Yrs)
1.155990E-03
Normal-vs-Age(81-100Yrs)
2.780200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.305800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.115400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.315000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.424000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.933200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.380400E-04
Normal-vs-Daily Drinker
1.390740E-04
Normal-vs-Weekly Drinker
3.135900E-03
Normal-vs-Occasional Drinker
3.136100E-02
Normal-vs-Social Drinker
4.838700E-03
Non Drinker-vs-Daily Drinker
2.840000E-01
Non Drinker-vs-Weekly Drinker
7.906200E-01
Non Drinker-vs-Occasional Drinker
8.211600E-01
Non Drinker-vs-Social Drinker
5.431400E-01
Daily Drinker-vs-Weekly Drinker
5.423200E-01
Daily Drinker-vs-Occasional Drinker
6.740400E-01
Daily Drinker-vs-Social Drinker
1.346240E-01
Weekly Drinker-vs-Occasional Drinker
9.798800E-01
Weekly Drinker-vs-Social Drinker
4.698800E-01
Occasional Drinker-vs-Social Drinker
5.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.638620E-01
Normal-vs-Grade 2
1.965820E-02
Normal-vs-Grade 3
3.085600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.874200E-02
Grade 1-vs-Grade 3
6.983700E-02
Grade 1-vs-Grade 4
1.638620E-01
Grade 2-vs-Grade 3
6.961200E-01
Grade 2-vs-Grade 4
1.965820E-02
Grade 3-vs-Grade 4
3.085600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.616200E-03
Normal-vs-NonDiabetic
4.621200E-04
Diabetic-vs-NonDiabetic
9.093800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.802300E-04
Normal-vs-NoPancreatitis
1.598800E-03
Pancreatitis-vs-NoPancreatitis
4.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.021900E-03
Normal-vs-N1
3.056800E-03
N0-vs-N1
3.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.142300E-03
Normal-vs-TP53-NonMutant
8.843800E-03
TP53-Mutant-vs-TP53-NonMutant
7.211000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
